advertisement
11.14 Investigational drugs; pharmacological experiments (12)
Showing records 1 to 12
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments15272 Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat
Schuettauf F; Rejdak R; Thaler S; Bolz S; Lehaci C; Mankowska A; Zarnowski T; Junemann A; Zagorski Z; Zrenner E
Experimental Eye Research 2006; 83: 1128-1134
15264 Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells
Schlieve CR; Tam A; Nilsson BL; Lieven CJ; Raines RT; Levin LA
Experimental Eye Research 2006; 83: 1252-1259
15253 Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma
Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
American Journal of Ophthalmology 2006; 142: 1054-1056
14489 The effect of glycine with timoptol on the rabbit IOP physiological values
Veselovsky J; Olah Z; Vesela A; Gressnerova S
Česka a Slovenska Oftalmologie 2006; 62: 247-254
15120 Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid
Heiduschka P; Thanos S
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1512-1521
15054 Morphine-induced reduction of intraocular pressure and pupil diameter: role of nitric oxide
Dortch Carnes J; Russell KR
Pharmacology 2006; 77: 17-24
15205 A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model
Galassi F; Masini E; Giambene B; Fabrizi F; Uliva C; Bolla M; Ongini E
British Journal of Ophthalmology 2006; 90: 1414-1419
15265 Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-α release in vitro from activated rat mast cells
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Experimental Eye Research 2006; 83: 1335-1339
14782 Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbo nyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester
Oka T; Walkup RD; Tamada Y; Nakajima E; Tochigi A; Shearer TR; Azuma M
Neuroscience 2006; 141: 2139-2145
14718 Ocular hypotensive effects of an intratracheally delivered liposomal Δ9-tetrahydrocannabinol preparation in rats
Szczesniak A-M; Kelly MEM; Whynot S; Shek PN; Hung O
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 160-167
15202 Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study
Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
Journal of Glaucoma 2006; 15: 349-353
15263 Short-term exposure to transforming growth factor β induces long-term fibrotic responses
Wormstone IM; Anderson IK; Eldred JA; Dawes LJ; Duncan G
Experimental Eye Research 2006; 83: 1238-1245